Imaging and Quantification of the Hepatic Vasculature of Mice Using Ultrafast Doppler Ultrasound
July 19th, 2024
Ultrafast Doppler ultrasound (UFUS) with high spatial resolution (100 μm) and sensitivity represents a suitable noninvasive imaging modality for obtaining a comprehensive qualitative overview of the hepatic vasculature. UFUS also facilitates quantitative measurements of the microvasculature, aiming to enhance our understanding of vascular disease mechanisms.
Overview
This study presents a non-invasive ultrafast Doppler ultrasound (UFUS) imaging protocol for assessing liver vasculature in murine models. The method enhances both qualitative and quantitative evaluations of hepatic blood flow and microvasculature.
Key Study Components
Area of Science
- Ultrafast Doppler ultrasound imaging
- Liver vasculature assessment
- Non-invasive imaging techniques
Background
- Ultrafast ultrasound technology improves sensitivity and spatial resolution.
- It allows for detailed visualization of small blood vessels.
- Standardized procedures enhance data analysis and reproducibility.
- Current imaging methods include UFUS and 3D micro-CT.
Purpose of Study
- To develop a non-invasive imaging protocol for liver vasculature.
- To improve the accuracy of blood volume measurements.
- To facilitate the assessment of microcirculation without contrast agents.
Methods Used
- Preparation of anesthetized mice for imaging.
- Application of ultrasound transmission gel for optimal imaging.
- Utilization of a 10 millisecond Doppler ultrasound sequence.
- Analysis of vascular parameters using defined regions of interest.
Main Results
- Establishment of a robust imaging protocol for liver vasculature.
- Accurate quantification of mean hepatic blood volume.
- Clear visualization of anatomical structures and microcirculation.
- Standardized data analysis procedures enhance reproducibility.
Conclusions
- The UFUS protocol provides high-sensitivity liver imaging.
- It captures slow blood flow and small vessels effectively.
- The method improves accuracy by minimizing motion artifacts.
Frequently Asked Questions
Executive Industry Relevance
Non-invasive ultrafast Doppler ultrasound imaging of murine hepatic vasculature enables high-sensitivity, quantitative assessment of microcirculation, supporting early-stage discovery and translational research in liver disease models. The protocol's reproducibility and standardization facilitate robust vascular parameterization, reducing biological ambiguity and enhancing predictive confidence for preclinical portfolio decisions. This capability positions UFUS as a reusable platform for functional vascular analysis across discovery and preclinical inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional interrogation of hepatic vascular pathways in disease-relevant murine models.
- Supports biological de-risking by providing quantitative microcirculation data without contrast agents.
- Facilitates predictive confidence in target validation through reproducible vascular measurements.
Screening & Assay Development
- Prepares validated in vivo systems for downstream compound evaluation targeting hepatic vasculature.
- Standardizes imaging and quantification workflows, ensuring assay reproducibility and scalability.
- Delivers quantitative outputs suitable for comparative screening and longitudinal studies.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by enabling non-invasive, functional vascular assessment in live animals.
- Provides continuity from discovery through preclinical validation by supporting robust, repeatable measurements.
- De-risks advancement decisions by quantifying microvascular alterations relevant to disease progression.
Pipeline & Workflow Integration
Ultrafast Doppler ultrasound imaging integrates from early discovery through preclinical research, supporting hypothesis testing, target validation, and translational continuity in hepatic disease models.
- Discovery Biology: Quantitative imaging supports hypothesis-driven interrogation of hepatic vascular function.
- Screening: Standardized protocols enable reproducible, high-sensitivity readouts for compound evaluation.
- Analytics: Delivers robust blood volume and microcirculation metrics for cross-condition comparison.
- Translational Research: Non-invasive assessment aligns with biomarker development and preclinical validation needs.
- Enterprise Reuse: Protocol standardization and platform compatibility enable broad application across liver-focused R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in hepatic vascular studies.
- Operational Value: Enhances reproducibility, scalability, and standardization of in vivo imaging workflows.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling early, quantitative vascular assessment.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of liver disease programs.
Implementation Considerations
- Requires expertise in ultrafast Doppler ultrasound operation and anatomical interpretation.
- Needs access to high-frame-rate ultrasound platforms and compatible analysis software.
- Demands cross-team standardization of imaging and quantification protocols for reproducibility.
- Adaptation across different murine models may require anatomical reference alignment.
- Motion artifacts from respiration must be managed to ensure data integrity.
Biopharma FAQs
Chapters in this video
0:00
Introduction
2:03
Mouse Preparation for UFUS Imaging of the Hepatic Vasculature
3:13
Probe Operation and Plane Selection for Obtaining a Comprehensive Qualitative Overview of the Hepatic Vasculature
5:08
Doppler Scan Acquisition and Quantitative Measurement of Hepatic Blood Volume Using UFUS
